Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
2i and Supplementary Fig
Type 2 Diabetes Mellitus (T2DM): Cardiovascular Risk Reduction (off-label use): GLP-1 Agonist: Semaglutide, the active ingredient in Rybelsus, mimics the natural GLP-1 hormone , which plays a critical role in regulating blood sugar levels
Patent US 8,927,488
While cardiovascular outcome data for retatrutide is still accumulating, the prudent approach for anyone with active cardiovascular disease is to remain on compounds with established cardiovascular safety profiles
US$ 22.93
US$ 24.62
US$ 29.18
US$ 28.30
US$ 28.43
US$ 22.72
US$ 28.51
